Discovery explains why patients with severe asthma are unresponsive to treatment

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

Related Keywords

Houston ,Texas ,United States ,American ,Cynthia Koziol White ,Reynold Panettieri Jr ,Emily Henderson ,Rutgers Robert Wood Johnson Medical School ,Institute For Translational Medicine ,Genentech ,Texasam University ,Robert Wood Johnson Medical School ,Roche Group ,American Lung Association ,Science Translational Medicine ,American Lung ,Translational Medicine ,South San Francisco ,Asthma ,Fell ,Cell Proliferation ,Fibroblast ,Growth Factor ,Inflammation ,Medical School ,Medicine ,Proliferation ,Research ,Steroid ,